🇺🇸 FDA
Patent

US 10912791

Compositions comprising antisense-encoded erythropoietin receptor and use thereof

granted A61KA61K31/711A61K9/0019

Quick answer

US patent 10912791 (Compositions comprising antisense-encoded erythropoietin receptor and use thereof) held by The Board of Regents of the University of Texas System expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/711, A61K9/0019, A61K9/0053, A61K9/007